InvestorsHub Logo

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
crudeoil24 PremiumMember
05/11/20 8:28 AM
profile icon
TheFinalCD PremiumMember
05/11/20 8:18 AM
profile icon
rqtect Free
08/24/17 6:42 PM
profile icon
Whalatane PremiumMember
08/16/17 9:42 PM
profile icon
Whalatane PremiumMember
08/11/17 9:51 AM
profile icon
Bernstein Terminated
08/11/17 8:36 AM
profile icon
Whalatane PremiumMember
08/10/17 10:52 PM
profile icon
Bernstein Terminated
08/09/17 2:07 PM
profile icon
expediter13 Free
08/07/17 6:48 PM
profile icon
Bernstein Terminated
08/07/17 1:22 PM
profile icon
wiltonio Free
04/13/17 4:08 PM
profile icon
venturecapp Free
07/12/16 1:15 PM
profile icon
Eric33psc Free
06/17/16 8:36 PM
profile icon
stocktrademan Free
06/16/16 2:24 PM

MyoKardia Inc fka MYOK RSS Feed

Followers
6
Posters
13
Posts (Today)
0
Posts (Total)
17
Created
06/16/16
Type
Free
Moderators
MyoKardia, Inc. 333 Allerton Avenue South San Francisco, CA 94080 United States Phone: 650-741-0900 Website: http://www.myokardia.com MyoKardia, Inc., a clinical stage biopharmaceutical company, engages in discovering, developing, and commercializing therapies for the treatment of serious and neglected rare cardiovascular diseases. Its lead product candidate is MYK-461, a small molecule that is in three Phase I clinical trials designed to reduce excessive cardiac muscle contractility leading to hypertrophic cardiomyopathy (HCM). The company also develops DCM-1, a drug compound that treats heritable dilated cardiomyopathy (DCM) by restoring normal contractility in the diseased DCM heart. In addition, it develops HCM-2, a product candidate to reduce cardiac muscle contractility to normal levels in HCM patients; and LUS-1, a product candidate, which is intended to counteract a muscle disruption that results in impaired relaxation of the heart. The company has a strategic collaboration with Sanofi S.A. MyoKardia, Inc. was founded in 2012 and is headquartered in South San Francisco, California.
Board Info
Posts Today
0
Posts (Total)
17
Posters
13
Moderators
New Post